NanoViricides
NNVC
#10585
Rank
S$42.48 M
Marketcap
S$1.66
Share price
-0.76%
Change (1 day)
-10.22%
Change (1 year)

EPS for NanoViricides (NNVC)

EPS in 2026 (TTM): S-$0.57

According to NanoViricides's latest financial reports the company's current EPS (TTM) is S-$0.56. In 2025 the company made an earnings per share (EPS) of S-$0.81 an increase over its 2024 EPS that were of S-$0.90.

EPS history for NanoViricides from 2005 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$0.57-28.85%
2025S-$0.81-10%
2024S-$0.90-5.41%
2023S-$0.955.71%
2022S-$0.90-13.58%
2021S-$1.04-66.11%
2020S-$3.061.7%
2019S-$3.01-10.98%
2018S-$3.38-22.35%
2017S-$4.35-10.53%
2016S-$4.87375%
2015S-$1.02-85.19%
2014S-$6.9142.11%
2013S-$4.8726.67%
2012S-$3.84-6.25%
2011S-$4.1014.28%
2010S-$3.59100%
2009S-$1.79-0%
2008S-$1.79-33.33%
2007S-$2.69-0%
2006S-$2.694445.07%
2005S-$0.05916

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
S-$3.33 490.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$1.62-387.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$5.81-1,131.82%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$4.09-826.74%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
S-$1.95 245.45%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
S-$1.84 227.27%๐Ÿ‡บ๐Ÿ‡ธ USA